MaxLinear Sees Q4 Sales $80.000M-$100.000M vs $88.31M Est
Portfolio Pulse from Benzinga Newsdesk
MaxLinear (NASDAQ:MXL) has provided guidance for Q4 sales between $80 million and $100 million, compared to the analyst estimate of $88.31 million.
October 23, 2024 | 8:29 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
MaxLinear's Q4 sales guidance of $80M-$100M is below the analyst estimate of $88.31M, which may lead to short-term stock price volatility.
The guidance range provided by MaxLinear is below the analyst estimate, which could lead to negative sentiment among investors and potential short-term downward pressure on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100